Infinium Pharmachem Gets In-Principle NSE Approval for Main Board Migration
Infinium Pharmachem Limited receives in-principle approval from NSE to migrate from the SME platform to the Main Board, affecting 15,583,120 equity shares.
ALFA News
Straight from the exchange filing
Infinium Pharmachem Limited receives in-principle approval from NSE to migrate from the SME platform to the Main Board, affecting 15,583,120 equity shares.